Preoperative intravenous iron administration corrects anemia and reduces transfusion requirement in women undergoing abdominal hysterectomy.
Preoperative intravenous iron administration corrects anemia and reduces transfusion requirement in women undergoing abdominal hysterectomy.
复制标题
DOI：
10.1111/j.1778-428x.2007.00060.x
复制
发表时间：
2007-01-01
期刊：
影响因子：
--
通讯作者：
Munoz, M.
中科院分区：
文献类型：
--
作者：
Diez-Lobo, A. I.;Fisac-Martin, M. P.;Munoz, M.
我们前瞻性地研究了术前静脉（IV）铁剂治疗在提高血红蛋白（Hb）水平和减少缺铁性贫血（IDA）或计划进行选择性腹部子宫切除术的缺铁（ID）女性的输血需求方面的效用。 75 名患有 ID 或 IDA 的女性参加了这项研究。术前评估后至少 1 个月进行手术的女性在 2-4 周内接受静脉注射蔗糖铁（静脉注射铁剂组，n=31）。术前评估几天后接受手术的女性没有接受静脉铁剂治疗（对照组，n=44）。基线时，两组在体重或年龄、贫血患病率、血红蛋白水平或铁实验室参数方面没有差异。 IV 蔗糖铁 (760290 mg) 增加术前 Hb (DeltaHb：2.21.2 g/dL；P
We prospectively investigated the utility of preoperative intravenous (IV) iron treatment to increase haemoglobin (Hb) levels and reduce the need for transfusion in women with iron deficiency anaemia (IDA) or iron deficiency (ID) scheduled for elective abdominal hysterectomy. Seventy-five women with ID or IDA were enrolled in the study. Women having their surgical procedure at least 1 month after preoperative assessment received IV iron sucrose during 2-4 weeks (IV iron group, n=31). Women having their surgical procedure a few days after preoperative assessment did not receive IV iron (control group, n=44). At baseline, there were no differences between the two groups in terms of weight or age, prevalence of anaemia, Hb levels or iron laboratory parameters. IV iron sucrose (760290 mg) increased preoperative Hb (DeltaHb: 2.21.2 g/dL; P